Advertisement

Intermediary metabolism and its regulation in parasitic worms in a strategy for chemotherapy

  • T. E. Mansour
Chapter

Abstract

The idea that a rational strategy for chemotherapy depends on selecting for chemical agents that are toxic to the parasite but not to the host was originally established by Paul Ehrlich in the early part of this century. While pharmacologists have always recognized Ehrlich’s basic concept of selective toxicity, the invading organism was looked upon for many years as a ‘black box’ subject. During the last twenty years it has become evident that knowledge of the biochemistry of the invading organism is of prime importance in implementing Ehrlich’s strategy for chemotherapy. Knowledge about the biochemistry and genetics of bacterial and viral species has led to the development of selective chemotherapeutic agents against the invading organism. Even when an antibacterial or antiviral agent is discovered as the result of a ‘blind’ screening programme it has often been possible to identify the site of action of these new chemotherapeutic agents. Such studies in many cases have led to the uncovering of new sites in the invading organism that are amenable to further pharmacological manipulation.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BENNETT, J.L. & BUEDING, E. (1973). Uptake of 5-hydroxytryptamine by Schistosoma mansoni. Mol. Pharmac, 9, 311–319.Google Scholar
  2. BUEDING, E. & MANSOUR, J.M. (1957). The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni. Br. J. Pharmac. Chemother., 12, 159–165.CrossRefGoogle Scholar
  3. BUZNIKOV, G.A., CHUDAKOVA, I.V., BERDYSHEVA, L.V. & VYAZMINA, N.M. (1968). The role of neurohumors in early embryogenesis. II. Acetylcholine and catecholamine content in developing embryos of sea urchin. J. Embryol. exp. Morph., 20, 119–128.Google Scholar
  4. BUZNIKOV, G.A., KOST, A.N., KUCHEROVA, N.F., MCDZHOYAN, A.L. SUVAROV, M.N. & BERDYSHEVA, L.V. (1970). The role of neurohumors in early embryo-genesis. III. Pharmacological analysis of the role of neurohumors in cleavage division. J. Embryol. exp. Morph, 23, 549–569.Google Scholar
  5. CATTO, B.A. (1981). Schistosoma mansoni: decarboxylation of 5-hydroxytryptophan, L-dopa, and L-histidine in adult and larval schistosomes. Expl. Parasitol, 51, 152–157.CrossRefGoogle Scholar
  6. CHANCE, M.R.A. & MANSOUR, T.E. (1949). A kymographic study of the action of drugs on the liver fluke (Fasciola hepatica). Br. J. Pharmac, 4, 7–13.Google Scholar
  7. DOBSON, C. (1966a). The effects of thiouracil and thyroxine on the host-parasite relationship of Am-plicaecum robertsi in the mouse. Parasitology, 56, 425–429.CrossRefGoogle Scholar
  8. DOBSON, C. (1966b). The effects of pregnancy and treatment with progesterone on the host-parasite relationship of Amplicaecum robertsi in the mouse. Parasitology, 56, 417–424.CrossRefGoogle Scholar
  9. DRUMMOND, A.H., BUCHER, F. & LEVITÄN I.B. , (1980). d[3H]Lysergic acid diethylamide binding to serotonin receptors in the molluscan nervous system. J. biol. Chem., 255, 6679.Google Scholar
  10. DUNSMORE, J.D. (1961). Effect of whole-body irradiation and cortisone on the development of Ostertagia spp. in sheep. Nature, 192, 139–140.CrossRefGoogle Scholar
  11. ESTEY, S.J., MANSOUR, J.M. & MANSOUR, T.E. (1984). Serotonin-activated adenylate cyclase in Schistosoma mansoni during development. IUPHAR 9th International Congress of Pharmacology, London 1984, Abstracts no 105P.Google Scholar
  12. GENTLEMAN, S., ABRAHAMS, S.L. & MANSOUR, T.E. (1976). Cyclic adenosine 3’,5’-monophosphate in the liver fluke, Fasciola hepatica. II. Activation of protein kinase by 5-hydroxytryptamine. Mol Pharmac, 12, 59–68.Google Scholar
  13. GUSTAFSON, T. & TONEBY, M. (1970). On the role of serotonin and acetylcholine in sea urchin morphogenesis. Expl. Cell Res., 62, 102–117.CrossRefGoogle Scholar
  14. HOULT, D.I., BUSBY, S.J.W., GADIAN, D.G., RADDA, G.K., RICHARDS, R.E. & SEELEY, P.J. (1974). Observations of tissue metabolites using 31P nuclear magnetic resonance. Nature, 252, 285–287.CrossRefGoogle Scholar
  15. HUTTON, J.C., SCHOFIELD, P.J. & McMANUS, W.R. (1972). Metabolic sensitivity of Fasciola hepatica to mammalian hormones in vitro. Comp. Biochem. Physiol., 42, 49–56.Google Scholar
  16. KASSCHAU, M.R. & MANSOUR, T.E. (1982a). Adenylate cyclase in adults and cercariae of Schistosoma mansoni. Mol. Biochem. Parasitol., 5, 107–116.CrossRefGoogle Scholar
  17. KASSCHAU, M.R. & MANSOUR, T.E. (1982b). Serotonin-activated adenylate cyclase during early development of Schistosoma mansoni. Nature, 296, 66–68.CrossRefGoogle Scholar
  18. MANSOUR, T.E. (1959). The effect of serotonin and related compounds on the carbohydrate metabolism of the liver fluke, Fasciola hepatica. J. Pharmac. exp. Ther., 126, 212.Google Scholar
  19. MANSOUR, T.E. (1964). The pharmacology and biochemistry of parasitic helminths. Adv. Pharmac, 3, 129–165.CrossRefGoogle Scholar
  20. MANSOUR, T.E. (1972). Phosphofructokinase. Curr. Top. Cell. Regul.,J, 1–46.Google Scholar
  21. MANSOUR, T.E. (1979). Chemotherapy of parasitic worms: New biochemical strategies. Science, 205, 462–469.CrossRefGoogle Scholar
  22. MANSOUR, T.E. (1984). Serotonin receptors in parasitic worms. Adv. Parasitol., 23, 1–36.CrossRefGoogle Scholar
  23. MANSOUR, T.E. & BUEDING, E. (1954). Action of antimonials on glycolysis of Schistosoma mansoni. Br. J. Pharmac, 9, 459–462.Google Scholar
  24. MANSOUR, T.E. & MANSOUR, J.M. (1962). Effects of serotonin (5-hydroxytryptamine) and adenosine 3’,5’-phosphate on phosphofructokinase from the liver fluke Fasciola hepatica. J. biol. Chem., 237, 629–634.Google Scholar
  25. MANSOUR, T.E. & MANSOUR, J.M. (1977). Phosphodiesterase from the liver fluke Fasciola hepatica. Biochem. Pharmac, 26, 2325–2330.CrossRefGoogle Scholar
  26. MANSOUR, T.E. & MANSOUR, J.M. (1984). Serotonin-activated adenylate cyclase (AC) in trematodes. Abstracts of the 4th Congress of the Pan. Amer. Assoc, of Biochem. Soc. (in press).Google Scholar
  27. MANSOUR, T.E. & STONE, D.B. (1970). Biochemical effects of lysergic acid diethylamide on the liver fluke Fasciola hepatica. Biochem. Pharmac, 19, 1137–1145.CrossRefGoogle Scholar
  28. MANSOUR, T.E., LAGO, A.D. & HAWKINS, J.L. (1957). Occurrence and possible role of serotonin in Fasciola hepatica. Fedn. Proc, 16, 319.Google Scholar
  29. MANSOUR, T.E., SUTHERLAND, E.W., RALL, T.W. & BUEDING, E. (1960). The effect of serotonin on the formation of adenosine-3’,5’-phosphate by tissue particles from the liver fluke, Fasciola hepatica. J. biol. Chem., 235, 466–470.Google Scholar
  30. MANSOUR, T.E., MORRIS, P.G., FEENEY, J. & ROBERTS, G.C.K. (1982). A 31P NMR study of the intact liver fluke Fasciola hepatica. Biochim. biophys. Acta, 721, 336–340.CrossRefGoogle Scholar
  31. McMAHON, D. (1974). Chemical messengers in development: A hypothesis. Science 185, 1012–1021.CrossRefGoogle Scholar
  32. McNALL, S.J. & MANSOUR, T.E. (1984). Novel serotonin receptors in Fasciola: Characterization by studies on adenylate cyclase activation and pH]LSD binding. Biochem. Pharmac (in press).Google Scholar
  33. MATTHEWS, P.A., SHEN, L., FOXALL, D.L. & MANSOUR, T.E. (1984). NMR studies of carbohydrate metabolism in Fasciola hepatica. Abstracts of the 25th Exp. NMR Conference, Wilmington, DE, USA. April, 1984. Abstract 1,C,1.Google Scholar
  34. NORTHUP, J.K. & MANSOUR, T.E. (1978a). Adenylate cyclase from Fasciola hepatica: 1. Ligand specificity of adenylate cyclase-coupled serotonin receptors. Mol. Pharmac, 14, 804–819.Google Scholar
  35. NORTHUP, J.K. & MANSOUR, T.E. (1978b). Adenylate cyclase from Fasciola hepatica. 2. Role of guanine nucleotides in coupling adenylate cyclase and serotonin receptors. Mol. Pharmac, 14, 820–833.Google Scholar
  36. PEROUTKA, S.J., LEBOVITZ, R.M. & SNYDER, S.H. (1981). Two distinct central serotonin receptors with different physiological functions. Science, 212, 827–829.CrossRefGoogle Scholar
  37. SCHULMAN, R.G., BROWN, T.R., UGURBIL, K., OGAWA, S., COHEN, S.M. & DEN HOLLANDER, J.A. (1979). Cellular applications of 31P and 13C nuclear magnetic resonance. Science, 205, 160–166.CrossRefGoogle Scholar
  38. SHEN, L., MATTHEWS, P.A., FOXALL, D.L. & MANSOUR, T.E. (1984). 31P NMR quantitative study of the liver fluke Fasciola hepatica. Proc. of XXIInd Ampere Congress on Magnetic Resonance and Related Phenomena. Zurich, Sept. 10–15,1984. (in press).Google Scholar
  39. STONE, D.B. & MANSOUR, T.E. (1967a). Phosphofructokinase from the liver fluke, Fasciola hepatica. 1. Activation by adenosine 3’,5’-phosphate and by serotonin. Mol. Pharmac, 3, 161–176.Google Scholar
  40. STONE, D.B. & MANSOUR, T.E. (1967b). Phosphofructokinase from the liver fluke, Fasciola hepatica. 2. Kinetic properties of the enzyme. Mol. Pharmac, 3, 177–187.Google Scholar
  41. TIELENS, A.G.M., NICOLAY, K. & VAN DEN BERGH, S.G. (1982). 31P-NMR studies of pH homeostasis in intact adult Mol. Biochem. Fasciola hepatica. Parasitol, 6, 175–180.Google Scholar

Copyright information

© Macmillan Publishers Limited 1984

Authors and Affiliations

  • T. E. Mansour
    • 1
  1. 1.Department of PharmacologyStanford University School of MedicineStanfordUSA

Personalised recommendations